Every S-3 that GoHealth, Inc. (GOCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow GOCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GOCO filings page.
GoHealth, Inc. has filed a resale registration covering up to 9,566,028 shares of its Class A common stock. These shares may be sold from time to time by the selling stockholder, Centerbridge, using methods such as brokered trades, underwritten offerings, private sales, or other transactions at market or negotiated prices.
GoHealth is not selling any shares in this offering and will not receive any proceeds; Centerbridge will receive all sale proceeds and pay any underwriting discounts and selling commissions. The registered shares include 5,386,178 shares issuable upon exchange of GoHealth Holdings, LLC interests and cancellation of an equal number of Class B shares. GoHealth’s Class A stock trades on Nasdaq under the symbol “GOCO,” and 16,093,116 Class A shares were outstanding as of December 11, 2025.
GoHealth, Inc. has filed an amended shelf registration to allow selling stockholders to resell up to 12,026,489 shares of its Class A common stock from time to time. These shares include 7,260,270 shares held or issuable to pre‑IPO investors through exchanges of LLC Interests and 4,766,219 shares issued to certain lenders in connection with credit agreement amendments and a new superpriority credit facility. The company itself is not selling any shares in this registration and will receive no proceeds from these resales, while the selling stockholders will bear any underwriting discounts and selling commissions. GoHealth’s Class A stock trades on Nasdaq under the symbol “GOCO,” and 16,093,116 shares of Class A common stock were outstanding as of November 13, 2025. The filing also summarizes GoHealth’s multi‑class capital structure, Series A convertible preferred stock, and governance and anti‑takeover provisions.
GoHealth, Inc. has filed a shelf registration statement covering the resale of up to 4,766,219 shares of its Class A common stock by a group of lending institutions that received the shares in a private placement. The company is not selling any shares in this offering and will not receive proceeds from sales made by these selling stockholders, who will bear any underwriting discounts and commissions.
The registered shares were issued as consideration for lenders entering into an amendment to GoHealth’s existing credit agreement and a new superpriority senior secured “priming” credit facility, which also coincided with board changes and the creation of a Transformation Committee focused on strategic alternatives. As context, GoHealth had 16,093,116 shares of Class A common stock outstanding as of November 13, 2025, and its Class A stock trades on Nasdaq under the symbol “GOCO”.